This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Menu
Book
Key Sessions
Bahija Jallal
Advances in Bispecific, Soluble TCR Therapies
Immunocore
June 10 - Live Sessionskeyboard_arrow_right

June 10 - Live Sessions - BST (British Summer Time, GMT+1)

keyboard_arrow_leftSearch & Filter
search

June 10 - Live Sessions - BST (British Summer Time, GMT+1)

search
June 10 - Live Sessions 09:45 - 10:1530 mins
Scientific Briefing
    June 10 - Live Sessions 10:30 - 11:0030 mins
    Scientific Briefing
      June 10 - Live Sessions 11:15 - 12:1560 mins
      Keynote Presentation with Introduction by Session Chair
      Advances in Bispecific, Soluble TCR Therapies
      • Bahija Jallal - Chief Executive Officer, Immunocore
      To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
      June 10 - Live Sessions 12:30 - 13:1545 mins
      Live Panel Discussion & Speaker Q&A
      New Approaches to Multispecific Antibody Treatment
      • Paul Parren, PhD - EVP, Head of R&D and Professor, Lava Therapeutics and Leiden University
      • Aran Labrijn, PhD - Principal Scientist, Antibody Research and Technology, Genmab
      • Dimitris Skokos , Ph.D. - Senior Director, Cancer Immunology, Regeneron Pharmaceuticals
      • Paul Moore, Ph.D. - Vice President, Immunology & Cell Biology, MacroGenics
      • Marcel Walser, Ph.D. - Senior Director Research, Molecular Partners
      • Chan Cao, Ph.D. - Chief Executive Officer, Assembly Medicine LLC
      • Nizar El-Murr, Ph.D. - Principal Scientist - Immuno-Oncology Research, Sanofi
      June 10 - Live Sessions 14:15 - 14:4530 mins
      Scientific Briefing
        June 10 - Live Sessions 15:00 - 15:3030 mins
        Scientific Briefing
        Scientific Briefing
          To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting
          June 10 - Live Sessions 15:45 - 16:3045 mins
          Live Panel Discussion & Speaker Q&A
          Exploiting and Understanding Avidity Engineering of Antibodies
          • Greg Lazar, Ph.D. - Director and Senior Scientist, Antibody Engineering, Genentech
          • Daniel Lingwood - Assistant Professor of Medicine, The Ragon Institute of MGH, MIT and Harv
          • Harald Wajant, Ph.D. - Professor, Department of Internal Medicine II, University Hospital Würzburg
          • Nicholas Agard, Ph.D. - Senior Scientist, Antibody Engineering, Genentech
          • Simone Oostindie - Scientist, Early Stage Translational Research, Genmab
          • Friedrich Koch-Nolte, PhD - Professor of Immunology and Molecular Biology, University Medical Center Hamburg-Eppend
          June 9 - Live Sessions
          NextPost-Conf Training Course - Intro to Bioconjugates & ADCs - June 15-17
          Filter
          Streams
          Formats
          Choose Day